Announcement PDF RNS Number : 7917E OptiBiotix Health PLC 01 November 2022 OptiBiotix Health plc ("OptiBiotix" or the "Company" or the "Group") Launch of GoFigure products on Tmall China OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, announces the opening of an online shop on Tmall.com ("Tmall") for its Go-Figure products and it has launched GoFigure shakes containing patented weight management aid SlimBiome® on Tmall China. Tmall is a cross-border marketplace for foreign brands and merchants to sell directly to Chinese consumers in China. By selling on Tmall, brands and merchants no longer require a legal entity in China nor hold stock in the country. OptiBiotix has teamed up with certified Tmall Partner, Agency InReady, to build, promote and operate its Tmall store as this requires a specialised and dedicated cross-functional team with a proven track record. GoFigure is OptiBiotix's direct-to-consumer (D2C) range of weight management products formulated with core ingredient SlimBiome®. The GoFigure range of products consists of powdered meal replacement & beverage products (shakes, smoothies, pancake mixes, etc.) and healthy snacking (crisps, puffs, gummies, etc.). GoFigure is also available as private label range. SlimBiome® is a patented prebiotic weight management aid used by itself or in formulated products in the health & wellness, sports nutrition and weight management categories. SlimBiome® is supported by independent human studies which show it reduces hunger, cravings for sweet and savoury foods and fat intake, and helps people follow a low calorie diet plan. Consumers who used SlimBiome® in combination with a calorie restricted diet experience a relief from feeling hungry and have fewer cravings for food, leading to easier and more sustainable dieting and lose on average an additional 2kg per month, improving body composition. René Kamminga, CEO of OptiBiotix Limited, a wholly owned subsidiary of OptiBiotix Health plc, commented: "I am very pleased with the launch of our own Tmall store and that we can now focus on getting the GoFigure range direct to the Chinese consumer. The GoFigure range has been specifically formulated to support consumers aiming to reduce their weight, help them stick to their change in diet and improve their gut microbiome at the same time. This particular range has been adapted specifically to fit the consumer preferences in China and we are confident that we can build lasting success with our partner InReady." For further information, please contact: OptiBiotix Health plc Stephen O'Hara, Chief Executive Cenkos Securities plc (Broker) Callum Davidson / Neil McDonald Michael Johnson / Russell Kerr (Sales) Walbrook PR Ltd Anna Dunphy www.optibiotix.com Contact via Walbrook below Tel: 020 7397 8900 Mob: 07876 741 001 This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach. This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NRAEAKEFDFKAFFA